TD Asset Management Inc. Purchases 3,798 Shares of Teleflex Incorporated (TFX)

TD Asset Management Inc. increased its position in Teleflex Incorporated (NYSE:TFX) by 2.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 146,150 shares of the medical technology company’s stock after buying an additional 3,798 shares during the quarter. TD Asset Management Inc. owned 0.32% of Teleflex worth $38,889,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in the company. Private Advisor Group LLC increased its stake in shares of Teleflex by 21.1% in the third quarter. Private Advisor Group LLC now owns 2,848 shares of the medical technology company’s stock valued at $758,000 after buying an additional 496 shares during the period. Oregon Public Employees Retirement Fund increased its stake in shares of Teleflex by 2.3% in the third quarter. Oregon Public Employees Retirement Fund now owns 23,460 shares of the medical technology company’s stock valued at $6,242,000 after buying an additional 534 shares during the period. Frontier Capital Management Co. LLC increased its stake in shares of Teleflex by 8.0% in the third quarter. Frontier Capital Management Co. LLC now owns 215,428 shares of the medical technology company’s stock valued at $57,323,000 after buying an additional 15,908 shares during the period. Arizona State Retirement System increased its stake in shares of Teleflex by 2.8% in the third quarter. Arizona State Retirement System now owns 32,517 shares of the medical technology company’s stock valued at $8,652,000 after buying an additional 897 shares during the period. Finally, Russell Investments Group Ltd. increased its stake in shares of Teleflex by 198.4% in the third quarter. Russell Investments Group Ltd. now owns 223,450 shares of the medical technology company’s stock valued at $59,429,000 after buying an additional 148,559 shares during the period. 89.36% of the stock is owned by institutional investors.

TFX has been the subject of several recent research reports. Morgan Stanley lowered their price objective on Teleflex from $310.00 to $295.00 and set an “overweight” rating for the company in a research note on Friday, August 3rd. Needham & Company LLC raised Teleflex from a “buy” rating to a “strong-buy” rating and upped their price objective for the company from $279.00 to $300.00 in a research note on Monday, September 10th. Barclays started coverage on shares of Teleflex in a research report on Monday, October 15th. They set an “equal weight” rating and a $266.00 target price for the company. TheStreet downgraded shares of Teleflex from a “b” rating to a “c+” rating in a research report on Friday, August 3rd. Finally, Piper Jaffray Companies increased their target price on shares of Teleflex to $310.00 and gave the company an “overweight” rating in a research report on Friday, November 2nd. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Teleflex presently has an average rating of “Buy” and an average target price of $289.38.

In other Teleflex news, VP Thomas Anthony Kennedy sold 20,635 shares of the stock in a transaction that occurred on Wednesday, September 19th. The shares were sold at an average price of $268.91, for a total transaction of $5,548,957.85. Following the completion of the sale, the vice president now owns 6,046 shares of the company’s stock, valued at approximately $1,625,829.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Thomas E. Powell sold 5,200 shares of the stock in a transaction that occurred on Tuesday, October 30th. The stock was sold at an average price of $240.00, for a total value of $1,248,000.00. Following the transaction, the insider now owns 15,351 shares in the company, valued at $3,684,240. The disclosure for this sale can be found here. Insiders have sold a total of 89,160 shares of company stock valued at $22,760,153 in the last three months. Insiders own 2.56% of the company’s stock.

NYSE:TFX opened at $264.51 on Friday. The company has a market cap of $11.84 billion, a price-to-earnings ratio of 31.49, a PEG ratio of 2.08 and a beta of 1.12. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.26 and a quick ratio of 1.51. Teleflex Incorporated has a fifty-two week low of $227.52 and a fifty-two week high of $288.78.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 1st. The medical technology company reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.41 by $0.11. The business had revenue of $609.70 million during the quarter, compared to the consensus estimate of $609.05 million. Teleflex had a net margin of 2.81% and a return on equity of 18.04%. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.12 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 9.91 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 14th. Shareholders of record on Thursday, November 15th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date is Wednesday, November 14th. Teleflex’s dividend payout ratio is presently 16.19%.

WARNING: This piece of content was reported by WKRB News and is the property of of WKRB News. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.wkrb13.com/2018/11/09/td-asset-management-inc-purchases-3798-shares-of-teleflex-incorporated-tfx.html.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Further Reading: Are Wall Street analysts’ stock ratings worth following?

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply